These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16678140)

  • 21. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification.
    Crotti L; Spazzolini C; Schwartz PJ; Shimizu W; Denjoy I; Schulze-Bahr E; Zaklyazminskaya EV; Swan H; Ackerman MJ; Moss AJ; Wilde AA; Horie M; Brink PA; Insolia R; De Ferrari GM; Crimi G
    Circulation; 2007 Nov; 116(21):2366-75. PubMed ID: 17984373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long QT syndrome: reduced repolarization reserve and the genetic link.
    Roden DM
    J Intern Med; 2006 Jan; 259(1):59-69. PubMed ID: 16336514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long QT syndrome: from clinical discovery to molecular etiopathogenesis].
    Czajkowski V; Kulbertus H
    Rev Med Liege; 1998 Apr; 53(4):199-207. PubMed ID: 9641014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications.
    Tan HL; Bardai A; Shimizu W; Moss AJ; Schulze-Bahr E; Noda T; Wilde AA
    Circulation; 2006 Nov; 114(20):2096-103. PubMed ID: 17088455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome.
    Schwartz PJ; Vanoli E; Crotti L; Spazzolini C; Ferrandi C; Goosen A; Hedley P; Heradien M; Bacchini S; Turco A; La Rovere MT; Bartoli A; George AL; Brink PA
    J Am Coll Cardiol; 2008 Mar; 51(9):920-9. PubMed ID: 18308161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
    Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
    Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Atrial fibrillation in the long QT syndrome].
    Zienciuk A; Szwoch M; Raczak G
    Kardiol Pol; 2009 Jun; 67(6):681-4, discussion 685-6. PubMed ID: 19618328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
    Wegener FT; Ehrlich JR; Hohnloser SH
    Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
    [No Abstract]   [Full Text] [Related]  

  • 29. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young.
    Tester DJ; Ackerman MJ
    J Am Coll Cardiol; 2007 Jan; 49(2):240-6. PubMed ID: 17222736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal muscle involvement in congenital long QT syndrome.
    Finsterer J; Stöllberger C
    Neurol Sci; 2004 Oct; 25(4):238-40. PubMed ID: 15549512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothyroidism and congenital long QT: additive effect causing torsades?
    Elsheshtawy M; Yang F; Khanna A
    Europace; 2018 Apr; 20(4):635. PubMed ID: 29016752
    [No Abstract]   [Full Text] [Related]  

  • 32. A hydrophobicity-dependent motif responsible for surface expression of cardiac potassium channel.
    Pan N; Sun J; Lv C; Li H; Ding J
    Cell Signal; 2009 Feb; 21(2):349-55. PubMed ID: 19041715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome.
    Nishio Y; Makiyama T; Itoh H; Sakaguchi T; Ohno S; Gong YZ; Yamamoto S; Ozawa T; Ding WG; Toyoda F; Kawamura M; Akao M; Matsuura H; Kimura T; Kita T; Horie M
    J Am Coll Cardiol; 2009 Aug; 54(9):812-9. PubMed ID: 19695459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of Holter monitoring in patients with the long QT syndrome.
    Eggeling T; Osterhues HH; Hoeher M; Gabrielsen FG; Weismueller P; Hombach V
    Cardiology; 1992; 81(2-3):107-14. PubMed ID: 1286468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine.
    Luzza F; Raffa S; Saporito F; Oreto G
    Int J Clin Pract; 2006 May; 60(5):606-8. PubMed ID: 16700864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal repolarization dynamics revealed in exercise test in long QT syndrome mutation carriers with normal resting QT interval.
    Hekkala AM; Viitasalo M; Väänänen H; Swan H; Toivonen L
    Europace; 2010 Sep; 12(9):1296-301. PubMed ID: 20566482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction: 'The long QT syndromes--from molecule to man'.
    Bergfeldt L
    J Intern Med; 2006 Jan; 259(1):4-6. PubMed ID: 16336509
    [No Abstract]   [Full Text] [Related]  

  • 38. Takotsubo cardiomyopathy and congenital long QT syndrome in a patient with a novel duplication in the Per-Arnt-Sim (PAS) domain of hERG1.
    Grilo LS; Pruvot E; Grobéty M; Castella V; Fellmann F; Abriel H
    Heart Rhythm; 2010; 7(2):260-5. PubMed ID: 20004623
    [No Abstract]   [Full Text] [Related]  

  • 39. Torsades de Pointes: 50 Years Later, Can We See It Coming?
    Davis AM
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003850. PubMed ID: 26839387
    [No Abstract]   [Full Text] [Related]  

  • 40. Fetal and neonatal presentation of long QT syndrome.
    Komarlu R; Beerman L; Freeman D; Arora G
    Pacing Clin Electrophysiol; 2012 Apr; 35(4):e87-90. PubMed ID: 21401653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.